MAPK3 and cancer: Thus, similar to chrysosplenol d, ERK activation by BCI, a dual MKP1/6 phosphatase inhibitor, which targets exclusively ERK1/2 [20,21], induced concentration-dependent toxicity in different cancer cell lines including MDA-MB-231.